Skip to content

Evaluating the Integration of Anxiety Screening and Basic Anxiety-Management Techniques into Interpersonal Group Psychotherapy (IPT-G): A Quasi-Experimental Pilot Study in Luwero, Uganda

Evaluating the Integration of Anxiety Screening and Basic Anxiety-Management Techniques into Interpersonal Group Psychotherapy (IPT-G): A Quasi-Experimental Pilot Study in Luwero, Uganda

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202607628909375
Enrollment
400
Registered
2026-07-07
Start date
2026-04-27
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders

Interventions

Standard interpersonal group therapy
Enhanced Interpersonal Group Psychotherapy

Sponsors

StrongMinds
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults aged 18 years and above. Residents of the selected sub-counties in Luwero District where the study is being conducted. Enrolled in StrongMinds Interpersonal Group Psychotherapy (IPT-G) groups during the study period. Screen positive for depressive and/or anxiety symptoms, defined as a score of 10 or above on the PHQ-9 and/or GAD-7. Able and willing to provide written informed consent to participate in the study. Available to participate in the 6-week IPT-G intervention period and follow-up assessments.

Exclusion criteria

Exclusion criteria: Presence of severe mental illness requiring specialized psychiatric care, such as active psychosis or severe bipolar disorder. Identified as being at high risk of suicide, requiring immediate clinical intervention beyond the scope of community-based IPT-G, according to StrongMinds risk assessment procedures. Severe cognitive impairment or intellectual disability that would prevent meaningful participation in group psychotherapy sessions. Current intoxication or severe substance use disorder that would interfere with the ability to participate in group therapy sessions.

Design outcomes

Primary

MeasureTime frame
Change in depressive symptom scores from baseline to 2-week and 3-month follow-up, measured using the PHQ-9. ;Change in anxiety symptom scores from baseline to 2-week and 3-month follow-up, measured using the GAD-7.

Secondary

MeasureTime frame
Psychological well-being, measured using the WHO-5 Well-Being Index. ;Life satisfaction, measured using the Cantril Self-Anchoring Ladder. ;Perceived control over life circumstances, measured using a single-item autonomy scale. ;Functional impairment/disability, measured using WHODAS 2.0. ;Perceived social support, measured using the Multidimensional Scale of Perceived Social Support .

Countries

Uganda

Contacts

Public ContactChristine Nanyondo

Programs Director

cnanyondo@strongminds.org+256700346102

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026